Intravenous N-Acetylcysteine for Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of Randomized, Controlled Trials

Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty

(2012) Emre Aslanger et al.   CORONARY ARTERY DISEASE

A randomized trial of intravenous N-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes

(2011) Zehra Jaffery et al.   CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS

In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis

(2011) C Quintavalle et al.   Cell Death & Disease

Effect of N-Acetylcysteine on Serum Creatinine and Kidney Function: Results of a Randomized Controlled Trial

(2010) Louise Moist et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS—A multicenter prospective controlled trial

(2010) Fatih Koc et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Impact of High-Dose N-Acetylcysteine Versus Placebo on Contrast-Induced Nephropathy and Myocardial Reperfusion Injury in Unselected Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

(2010) Holger Thiele et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

High-dose N-acetylcysteine for the Prevention of Contrast-induced Nephropathy

(2009) Hariprasad Trivedi et al.   AMERICAN JOURNAL OF MEDICINE

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

N-Acetylcysteine does not artifactually lower plasma creatinine concentration

(2008) M. Haase et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION